Cargando…
Institutional factors associated with early mortality of newly diagnosed acute promyelocytic leukemia
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755312/ https://www.ncbi.nlm.nih.gov/pubmed/36522307 http://dx.doi.org/10.1038/s41408-022-00767-6 |
_version_ | 1784851403415486464 |
---|---|
author | Matsuda, Kensuke Jo, Taisuke Matsui, Hiroki Fushimi, Kiyohide Yasunaga, Hideo Sugimoto, Koichi |
author_facet | Matsuda, Kensuke Jo, Taisuke Matsui, Hiroki Fushimi, Kiyohide Yasunaga, Hideo Sugimoto, Koichi |
author_sort | Matsuda, Kensuke |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9755312 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-97553122022-12-17 Institutional factors associated with early mortality of newly diagnosed acute promyelocytic leukemia Matsuda, Kensuke Jo, Taisuke Matsui, Hiroki Fushimi, Kiyohide Yasunaga, Hideo Sugimoto, Koichi Blood Cancer J Correspondence Nature Publishing Group UK 2022-12-15 /pmc/articles/PMC9755312/ /pubmed/36522307 http://dx.doi.org/10.1038/s41408-022-00767-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Correspondence Matsuda, Kensuke Jo, Taisuke Matsui, Hiroki Fushimi, Kiyohide Yasunaga, Hideo Sugimoto, Koichi Institutional factors associated with early mortality of newly diagnosed acute promyelocytic leukemia |
title | Institutional factors associated with early mortality of newly diagnosed acute promyelocytic leukemia |
title_full | Institutional factors associated with early mortality of newly diagnosed acute promyelocytic leukemia |
title_fullStr | Institutional factors associated with early mortality of newly diagnosed acute promyelocytic leukemia |
title_full_unstemmed | Institutional factors associated with early mortality of newly diagnosed acute promyelocytic leukemia |
title_short | Institutional factors associated with early mortality of newly diagnosed acute promyelocytic leukemia |
title_sort | institutional factors associated with early mortality of newly diagnosed acute promyelocytic leukemia |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755312/ https://www.ncbi.nlm.nih.gov/pubmed/36522307 http://dx.doi.org/10.1038/s41408-022-00767-6 |
work_keys_str_mv | AT matsudakensuke institutionalfactorsassociatedwithearlymortalityofnewlydiagnosedacutepromyelocyticleukemia AT jotaisuke institutionalfactorsassociatedwithearlymortalityofnewlydiagnosedacutepromyelocyticleukemia AT matsuihiroki institutionalfactorsassociatedwithearlymortalityofnewlydiagnosedacutepromyelocyticleukemia AT fushimikiyohide institutionalfactorsassociatedwithearlymortalityofnewlydiagnosedacutepromyelocyticleukemia AT yasunagahideo institutionalfactorsassociatedwithearlymortalityofnewlydiagnosedacutepromyelocyticleukemia AT sugimotokoichi institutionalfactorsassociatedwithearlymortalityofnewlydiagnosedacutepromyelocyticleukemia |